New 2021 Forecasts Released

New Data
innovation hub

Second Sight Medical (NASDAQ:EYES) is Profiled in this Database

Updated At 18 Aug, 2018

Start Free 7 Day Trial Now
Partial description of this company
Retinal prosthesis system that utilizes electrical stimulation to partially restore sight in patients blinded by outer retinal degeneration

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Second Sight Medical (NASDAQ:EYES) plus 4809 other startups.

Start Free 7 Day Trial Now

Learn More About Second Sight Medical (NASDAQ:EYES)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

More

Start Free 7 Day Trial Now

Our Clients

1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.jpg
bain.jpg
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.jpg
hospira.png
jlabs.jpg
kimberlyclark.png
merck.jpg
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
teleflex.jpg
terumo.png
zimmerbiomet.png